BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32482604)

  • 1. Hospitalization direct cost of adults with community-acquired pneumonia in Portugal from 2000 to 2009.
    Antunes C; Pereira M; Rodrigues L; Organista D; Cysneiros A; Paula F; Nunes B; Barbosa P; Bárbara C; Escoval A; Diniz A; Froes F
    Pulmonology; 2020; 26(5):264-267. PubMed ID: 32482604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
    Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
    Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with in-hospital mortality from community-acquired pneumonia in Portugal: 2000-2014.
    Pessoa E; Bárbara C; Viegas L; Costa A; Rosa M; Nogueira P
    BMC Pulm Med; 2020 Jan; 20(1):18. PubMed ID: 31964385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009.
    Froes F; Diniz A; Mesquita M; Serrado M; Nunes B
    Eur Respir J; 2013 May; 41(5):1141-6. PubMed ID: 22878871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
    Cupurdija V; Lazic Z; Petrovic M; Mojsilovic S; Cekerevac I; Rancic N; Jakovljevic M
    J Bras Pneumol; 2015; 41(1):48-57. PubMed ID: 25750674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
    Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
    Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database.
    Woodhead M; Welch CA; Harrison DA; Bellingan G; Ayres JG
    Crit Care; 2006; 10 Suppl 2(Suppl 2):S1. PubMed ID: 16934135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
    Goss CH; Rubenfeld GD; Park DR; Sherbin VL; Goodman MS; Root RK
    Chest; 2003 Dec; 124(6):2148-55. PubMed ID: 14665494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and lost productivity costs associated with avoidable hospital admissions.
    Rocha JVM; Marques AP; Moita B; Santana R
    BMC Health Serv Res; 2020 Mar; 20(1):210. PubMed ID: 32164697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
    Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
    Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospitalization costs of adult community-acquired pneumonia in England.
    Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
    J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
    Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
    BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-hospital mortality for community-acquired pneumonia in mainland Portugal between 2000 and 2009.
    Teixeira-Lopes F; Cysneiros A; Dias A; Durão V; Costa C; Paula F; Serrado M; Nunes B; Diniz A; Froes F
    Pulmonology; 2019; 25(2):66-70. PubMed ID: 30026065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
    Sato R; Gomez Rey G; Nelson S; Pinsky B
    Appl Health Econ Health Policy; 2013 Jun; 11(3):251-8. PubMed ID: 23605251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions.
    Choi MJ; Song JY; Noh JY; Yoon JG; Lee SN; Heo JY; Yoon JW; Jo YM; Cheong HJ; Kim WJ
    Medicine (Baltimore); 2017 Nov; 96(44):e8429. PubMed ID: 29095281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of hospitalized childhood community-acquired pneumonia: A retrospective cross-sectional study in Vietnam, Malaysia, Indonesia and the Republic of Korea.
    Tan KK; Dang DA; Kim KH; Kartasasmita C; Kim HM; Zhang XH; Shafi F; Yu TW; Ledesma E; Meyer N
    Hum Vaccin Immunother; 2018 Jan; 14(1):95-105. PubMed ID: 29125809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes and costs among seniors requiring hospitalization for community-acquired pneumonia in Alberta.
    Carriere KC; Jin Y; Marrie TJ; Predy G; Johnson DH
    J Am Geriatr Soc; 2004 Jan; 52(1):31-8. PubMed ID: 14687312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment costs of community-acquired pneumonia in an employed population.
    Colice GL; Morley MA; Asche C; Birnbaum HG
    Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community acquired pneumonia and direct hospital cost.
    Doruk S; Tertemiz KC; Kömüs N; Uçan ES; Kilinç O; Sevinç C
    Tuberk Toraks; 2009; 57(1):48-55. PubMed ID: 19533437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.